Novartis International AG / Sandoz invites young entrepreneurs to enter
Sandoz HACk, a global competition to help solve healthcare access
challenges . Processed and transmitted by Nasdaq Corporate Solutions.
The issuer is solely responsible for the content of this announcement.
-- Despite significant advances made by modern medicine, universal access to
healthcare is still arguably the single largest unmet medical need
-- Sandoz "HACk" - Healthcare Access Challenge - is a competition seeking
young people with innovative ideas to "reimagine" access to healthcare
-- Sandoz HACk is partnering with OpenIDEO - a global community that drives
collaboration, innovation and impact around the world's toughest problems
The digital press release with multimedia content can be accessed here:
http://multimediacapsule.thomsonone.com/novartis/launch-of-sandoz-hack-competition
Holzkirchen, September 28, 2016 - Sandoz, the Novartis generic and
biosimilar pharmaceutical division, today announces the launch of
Sandoz HACk - Healthcare Access Challenge - a global competition to
generate innovative ideas and solutions to help tackle some of the
world's most pressing healthcare access problems. The competition is
open for entries until November 30, 2016.
"As global healthcare costs continue to rise faster than economic growth,
health access will not improve without a major collaborative effort to
address the gap, driven by fresh thinking", said Richard Francis,
Division Head and CEO of Sandoz. "We believe that the biggest changes
often come from amazing, small ideas and with the launch of Sandoz HACk
we want to identify, promote and nurture creative ideas from around the
world to help reimagine access to healthcare."
Despite the significant advances made in modern medicine, more than two
billion people worldwide cannot access the medicines they need and more
than 400 million lack access to essential health services.[1] The
combined efforts of stakeholders across both public and private sectors,
including the pharmaceutical industry, not-for-profit organizations and
governments have made significant advances in tackling healthcare access
challenges worldwide. But these large scale systemic initiatives need to
be supported by community-led change, driven by innovative small scale
solutions that can make a big difference. This is why Sandoz is
launching Sandoz HACk, inviting people to generate novel solutions to
tackle key healthcare access challenges in local communities.
Mobile technology is radically altering how care is delivered and
received worldwide and the influence of mobile in healthcare is likely
to continue evolving in the future. In its inaugural year, Sandoz HACk
encourages today's generation of entrepreneurs and creative thinkers to
enter ideas that harness mobile health technologies - M-Health - to help
solve relevant local healthcare access challenges.
Sandoz HACk is open for entries from 18-35 year olds around the world.
Following a robust judging process, the six finalist entries will be
published on OpenIDEO http://www.openideo.com - a global community of
leading organizations and individuals working together to design
solutions to the world's biggest challenges. Entrants' ideas will be
refined and evolved in partnership with this online community before
being presented to a panel of judges. Three winners will be chosen and
awarded seed funding and mentorship to help bring their ideas to life.
Details of how to enter the competition and the terms and conditions can
be found on the:
-- Sandoz website - www.sandoz.com/makingaccesshappen
-- Sandoz Facebook page - www.facebook.com/sandozglobal
Join the conversation on Twitter and Facebook using SandozHACk.
For further details about Sandoz HACk partner, OpenIDEO visit
www.openideo.com.
About Sandoz
Sandoz is a global leader in generic and biosimilar pharmaceuticals. As
a division of the Novartis Group, our purpose is to discover new ways to
improve and extend people's lives. We contribute to society's ability to
support growing healthcare needs by pioneering novel approaches to help
people around the world access high-quality medicine. Our portfolio of
approximately 1000 molecules, covering all major therapeutic areas,
accounted for 2015 sales of USD 10.1 billion. In 2015, our products
reached more than 500 million patients and we aspire to reach one
billion. Sandoz is headquartered in Holzkirchen, in Germany's Greater
Munich area.
Sandoz is on Twitter. Sign up to follow @Sandoz_global at
http://twitter.com/Sandoz_Global.
For further details visit www.sandoz.com/makingaccesshappen
References
[1] WHO: Health in 2015; Access to Medicine Index 2015
# # #
Novartis Media Relations
Central media line: +41 61 324 2200
E-mail: media.relations@novartis.com
Eric Althoff Duncan Cantor
Novartis Global Media Relations Sandoz Global Communications
+41 61 324 7999 (direct) +49 8024 476 2497 (direct)
+41 79 593 4202 (mobile) +49 170 650 6067 (mobile)
eric.althoff@novartis.com duncan.cantor@sandoz.com
Chris Lewis Bernhard Schneider
Sandoz Global Communications Sandoz Global Communications
+49 8924 476 1906 (direct) +49 8024 476 2594
+49 174 244 9501 (mobile) +49 174 339 0862
chris.lewis@sandoz.com bernhard.schneider@sandoz.com
Media release (PDF): http://hugin.info/134323/R/2045054/763782.pdf
This announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the information
contained therein.
Source: Novartis International AG via Globenewswire
--- End of Message ---
Novartis International AG
P.O. Box Basel Switzerland
WKN: 904278;ISIN: CH0012005267;
http://www.novartis.com
(END) Dow Jones Newswires
September 28, 2016 01:15 ET (05:15 GMT)
